Mohammad Ali Fahmidekar

Learn More
Acinetobacter baumannii is an increasingly nosocomial pathogen throughout the world, and the occurrence of multidrug-resistant (MDR) species is increasing. The aim of this study is to present the antimicrobial effects of a newly synthesized imidazoacridine, 11-chloro-3-methyl-3H-imidazo(4,5-a)acridine (CMIA), against MDR clinical isolates of A. baumannii.(More)
  • 1